We have located links that may give you full text access.
Clinical Trial
Journal Article
Carpal-tunnel syndrome. Results of a prospective trial of steroid injection and splinting.
Journal of Bone and Joint Surgery. American Volume 1980 October
In order to define the role of steroid injection and splinting as a method of treatment of carpal-tunnel syndrome, a prospective study was performed on fifty hands in forty-one consecutive patients. All hands were treated with a single injection and three weeks of splinting. Follow-up ranged from a minimum of six months to a maximum of twenty-six months, with a mean of eighteen months. All hands had characteristic symptoms of median-nerve compression at the wrist and increased distal median motor latencies. Eleven (22 percent) of fifty hands were completely free of symptoms at the end of the follow-up period. Hands that initially had mild symptoms and findings of less than one year's duration, normal sensibility, normal thenar strength and mass, and one to two-millisecond prolongations of either distal median motor or sensory latencies had the most satisfactory responses to injections and splinting. Hands with severe symptoms of more than one year's duration and findings of atrophy, weakness, and distal motor latencies of more than six milliseconds or absent sensory responses had the poorest response to injections and experienced a high rate of relapse.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app